期刊文献+

有Duchenne肌营养不良家族史孕妇的产前基因诊断 被引量:2

Prenatal diagnosis of pregnant women with a family history of Duchenne muscular dystrophy
下载PDF
导出
摘要 目的对有Duchenne肌营养不良(Duchenne muscular dystrophy,DMD)家族史的孕妇进行产前诊断研究。方法 PCR检测胎儿的性别决定基因(SRY)和DMD基因常见缺失的18个外显子,同时用DMD基因的6个(CA)n重复序列STR位点进行连锁分析,对31例有DMD家族史的孕妇进行产前诊断;随访健康胎儿出生后的发育情况,评估产前诊断方法的可靠性。结果 32例胎儿(1例双胎)中,18例女性胎儿中有6例为DMD基因携带者;14例男性胎儿中4例为DMD患儿。结论对DMD高风险胎儿进行SRY基因检测,联合应用DMD基因的18个外显子检测和连锁分析能够准确、有效地产前诊断DMD。 Objective To study prenatal diagnosis of pregnant women with a family history of Duchenne muscular dystrophy(DMD).Methods SRY gene was detected in 31 pregnant women with a family history of DMD by PCR amplification.Among the pregnant women one had twin.The analysis of deletion for the 18 exons with higher deletion frequency and the linkage of 6(CA)n short tandem repeat(STR) in DMD gene were carried out.The reliability of prenatal diagnosis was assessed by follow-up of infant development.Results The test for SRY gene revealed 14 male and 18 female were in the 32 fetuses.The results of exon deletion test and linkage analysis for DMD gene showed that 6 in 18 female fetuses were DMD gene mutation carriers,and 4 in 14 male fetuses suffered from DMD.The consulting advices for medical termination were given to the 4 pregnant women with DMD fetus.Conclusions Our data suggests that SYR gene detection combined the detection of exon deletion test and the analysis for linkage of DMD gene should be an accurate and effective prenatal diagnosis strategy for DMD in high-risk fetuses.
出处 《临床检验杂志》 CAS CSCD 北大核心 2011年第3期179-181,共3页 Chinese Journal of Clinical Laboratory Science
基金 云南省十一五社会发展项目(2007CA008) 云南省高层次人才培引工程项目(20080C009)
关键词 DUCHENNE肌营养不良 基因 产前诊断 Duchenne muscular dystrophy DMD gene prenatal diagnosis
  • 相关文献

参考文献8

  • 1Pahnieri B, Tremblay JP, Daniele L. Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy[J]. Pediatr Transplant, 2010,14 (7) : 813-819.
  • 2Beggs AH, Koening M, Boyce FM, et al. Detection of 98% of DMD/ BMD gene deletion by polylnerase chain reaction [J]. Hum Genet, 1990,86( 1 ) : 45-48.
  • 3Chamberlain JS, Gibbs RA, Rainer JE,et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification[J]. Nucleic AcidsRes, 1988, 16(23) :11141-11156.
  • 4Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions. State of the art 2004 [ J ]. lnt J Androl, 2004, 27 (4) :240-249.
  • 5Clemens PR, Fenwick RG, Chamberlain JS, et al. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms [ J]. Am J Hum Genet, 1991, 49(5) :951-960.
  • 6Sugita H, Takeda S. Progress in muscular dystrophy research with special emphasis on gene therapy[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2010,86(7 ) :748-756.
  • 7朱海燕,邬玲仟,梁德生,夏家辉.DMD基因突变及突变检测技术研究进展[J].基础医学与临床,2005,25(11):975-981. 被引量:11
  • 8Ou Z, Li S, Li Q, et al. Duchenne muscular dystrophy in a female patient with a karyotype of 46, X, i ( X ) ( ql0 ) [ J ]. Tohoku J Exp Med, 2010,222(2) :149-153.

二级参考文献32

  • 1Beggs AH, Koenig M, Boyce FM, et al. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction[J].Hum Genet, 1990, 86:45-48.
  • 2Yau SC, Bobrow M, Mathew CG, et al. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis[J]. J Med Genet, 1996, 33(7) : 550 - 558.
  • 3White S, Kalf M, Liu Q, et al. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization[J]. Am J Hum Genet, 2002, 71: 365- 374.
  • 4Francesco M, Silvia T, Alessandra F. Dystrophin and mutations: one gene, several proteins, multiple phenotypes [ J ].Lancet Neurology, 2003, 2:731 - 740.
  • 5Joanna MW, Roland GR. The dystrophin lymphocyte promoter revisited : 4.5 - megabase intron, or artefact ? [ J ]. Neuromuscular Disorders, 2003, 13:17 - 20.
  • 6Wheway JM, Roberts RG. The dystrophin lymphocyte promoter revisited : 4.5- megabase intron, or artefact ? [ J ]. Neuromuscul Disorders, 2003, 13 : 17 - 20.
  • 7D'Souza VN, Nguyen TIM, Morris GE, et al. A novel dystrophin isoform is required for normal retinal electrophysiology[J] .Hum Mol Genet, 1995, 4: 837- 842.
  • 8Lidov HG, Selig S, Kunkel LM. Dpl40: a novel 140 ku CNS transcript from the dystrophin locus [ J ]. Hum Mol Genet,1995, 4 : 329 - 335.
  • 9Byers TJ, Lidov HG, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve [J]. Nature Genetics,1993, 4:77-81.
  • 10Bar S, Barnea E, Levy Z, et al. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution[J]. Biochemical J, 1990, 272: 557-560.

共引文献10

同被引文献29

  • 1朱宝生,焦存仙,朱姝,董旭东,胡云英,刘云霞,冯怀英,刘娟,唐新华,张云霞,王瑞红,祝杏珍,章晓梅.唐氏综合征发生率及其受产前筛查干预的研究[J].中华妇幼临床医学杂志(电子版),2005,1(1):20-22. 被引量:31
  • 2王斌,陈英耀,石琦,张洁,李军,钱序,朱怡蓓.我国唐氏综合征的疾病经济负担研究[J].中国卫生经济,2006,25(3):24-26. 被引量:90
  • 3Cuckle HS,Wald NJ,Lindenbaum RH.Maternal serum alphafetoprotein measurement:a screening test for Down syndrome.Lancet,1984,1:926-929.
  • 4Wald NJ,Rodeck C,Hackshaw AK,et al.First and second trimester antenatal screening for Down's syndrome:the results of the Serum,Urine and Ultrasound Screening Study (SURUSS).Health Technol Assess,2003,7:1-77.
  • 5Berry BJ,Li Z,Erickson JD,et al.Prevention of neural-tube defects with folic acid in China.China-U.S.Collaborative Project for Neural Tube Defect Prevention. N Engl J Med,1999,341:1485-1490.
  • 6De Wals P,Tairou F,Van Allen MI,et al.Reduction in neuraltube defects after folic acid fortification in Canada.N Engl J Med,2007,357:135-142.
  • 7Malone FD,Canick JA,Ball RH,et al.First-trimester or secondtrimester screening,or both,for Down's syndrome.N Engl J Med,2005,353:2001-201 1.
  • 8Ball RH,Caughey AB,Malone FD,et al.First-and secondTrimester evaluation of risk for Down syndrome.Obstet Gynecol,2007,110:10-17.
  • 9朱姝,朱宝生,冯怀英,李波,苏洁,张云霞,孟昱时,史纪芳,李苏云,章锦曼.562例胎儿核型分析及产前诊断指征的探讨[J].中华妇幼临床医学杂志(电子版),2007,3(6):304-307. 被引量:4
  • 10Laing NG, Davis MR, Bayley K, et al. Molecular diagnosis of Duchenne muscular dystrophy: past, present and future in relation to implementing therapies[J]. Clin Biochem Rev, 2011, 32(3): 129-134.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部